Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

March 30, 2026

Conditions
Obesity; Drug
Interventions
BEHAVIORAL

nutritional intervention

A nutrition guidance before initiation of AOM treatment include recommendations for food choices and eating habits to minimize the occurrence and severity of GI symptoms during the up-titration phase, will be given by registered dietitian (RD) from the study team. Next, each week, participants will provide weekly reports of GI symptoms occurrence and severity, by responding to queries sent via WhatsApp/SMS and for occurring symptoms, an automatically structured nutrition and behavioral treatment recommendations will be sent . If participants expressed an interest in personalized dietary guidance on this matter, the study team RD will contact him/her by telephone, within a range of 48 hours, to provide individualized recommendations. Three days after each report of GI symptom(s), participants will receive an additional message and will be asked to report the occurrence and severity of the GI symptom, and their compliance with the specific dietary instructions received.

Trial Locations (3)

40700

RECRUITING

Ariel University, Ariel

4941492

NOT_YET_RECRUITING

Rabin Medical Center, Beilinson Hospital, Petah Tikva

6971028

RECRUITING

Assuta Medical Center, Tel Aviv

All Listed Sponsors
lead

Ariel University

OTHER